364-DAY BRIDGE CREDIT AGREEMENT Dated as of June 25, 2019 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and MORGAN STANLEY SENIOR FUNDING, INC., as Administrative Agent MUFG BANK, LTD., as Syndication Agent MORGAN STANLEY...364-Day Bridge Credit Agreement • June 25th, 2019 • AbbVie Inc. • Pharmaceutical preparations • New York
This 364-Day Bridge Credit Agreement (this “Agreement”) dated as of June 25, 2019 (Local Time) is among AbbVie Inc., a Delaware corporation (the “Borrower”), the Lenders (as defined below) that are parties hereto and Morgan Stanley Senior Funding, Inc., as administrative agent (in such capacity, or any successor thereto appointed pursuant to Article VII, the “Administrative Agent”) for the Lenders.
TRANSACTION AGREEMENT dated as of June 25, 2019 among ABBVIE INC. VENICE SUBSIDIARY, LLC and ALLERGAN PLCTransaction Agreement • June 25th, 2019 • AbbVie Inc. • Pharmaceutical preparations • Delaware
This TRANSACTION AGREEMENT (this “Agreement”), dated as of June 25, 2019 is by and among AbbVie, a Delaware corporation (“AbbVie”), Venice Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of AbbVie (“Acquirer Sub”), and Allergan plc, an Irish public limited company with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (“Allergan”).
EXPENSES REIMBURSEMENT AGREEMENT dated as of June 25, 2019 between ABBVIE INC. and ALLERGAN PLCExpenses Reimbursement Agreement • June 25th, 2019 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS EXPENSES REIMBURSEMENT AGREEMENT (this “Agreement”), dated as of June 25, 2019, between AbbVie Inc., a Delaware corporation (hereinafter called “AbbVie”), and Allergan plc, a company incorporated in Ireland with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (hereinafter called “Allergan”).
